Showing results (101-110 of 149) with videos related to
Sort By:
Pageof 15
Anticancer Research|November 28, 2008
Molecular analysis of PDGFRA and PDGFRB genes by rapid single-strand conformation polymorphism (SSCP) in patients with core-binding factor leukaemias with KIT or FLT3 mutationAlessandra Trojani, Carla Barbara Ripamonti, Silvana Penco, et al.Leukemia Research|January 13, 2016
CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalitiesSabina Chiaretti, Fulvia Brugnoletti, Monica Messina, et al.Blood|August 6, 2011
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patientsGiuseppe Visani, Lara Malerba, Pietro Maria Stefani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2014
Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomesFabio Efficace, Franco Mandelli, Giuseppe Avvisati, et al.Blood|October 18, 2002
Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-upGiuseppe Avvisati, Maria Concetta Petti, Francesco Lo-Coco, et al.Haematologica|October 8, 2008
Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-upFrancesca Palandri, Fausto Castagnetti, Nicoletta Testoni, et al.European Journal of Haematology|November 21, 2008
Considerations in the treatment of multiple myeloma: a consensus statement from Italian expertsFrancesca Patriarca, Maria T Petrucci, Sara Bringhen, et al.The New England Journal of Medicine|October 21, 2020
Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in AdultsRobin Foà, Renato Bassan, Antonella Vitale, et al.Blood|January 25, 2002
Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized studyLuciana Annino, Maria Luce Vegna, Andrea Camera, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10Franco Mandelli, Marco Vignetti, Stefan Suciu, et al.Pageof 15